Biomarin Pharmaceutical Correlations

BMRN Stock

USD 71.40 0.59 0.82%

A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomarin Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomarin Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Biomarin Pharmaceutical Correlation With Market

Significant diversification

The correlation between Biomarin Pharmaceutical and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomarin Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Biomarin Stock, please use our How to Invest in Biomarin Pharmaceutical guide.

Moving together with Biomarin Stock

0.62	LUCD	Lucid Diagnostics	Pair Corr
0.71	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.66	T	ATT Inc Sell-off Trend	Pair Corr

Moving against Biomarin Stock

0.71	CMND	Clearmind Medicine Common	Pair Corr
0.68	SCLX	Scilex Holding	Pair Corr
0.59	MLSS	Milestone Scientific Earnings Call This Week	Pair Corr
0.57	ASMB	Assembly Biosciences Earnings Call Tomorrow	Pair Corr
0.52	CDIOW	Cardio Diagnostics	Pair Corr
0.47	WMT	Walmart	Pair Corr
0.39	OCEAW	Ocean Biomedical	Pair Corr
0.35	ELVN	Enliven Therapeutics	Pair Corr
0.83	CAT	Caterpillar	Pair Corr
0.83	HD	Home Depot	Pair Corr
0.72	MSFT	Microsoft Aggressive Push	Pair Corr
0.56	DIS	Walt Disney	Pair Corr
0.51	JPM	JPMorgan Chase	Pair Corr
0.49	BA	Boeing	Pair Corr

Related Correlations Analysis

	SGEN	ALNY	EXEL	HALO	ARWR	INCY	IONS	APLS	PCVX	LQDA
SGEN		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SGEN
ALNY	0.0		-0.34	0.38	0.16	0.12	-0.32	-0.15	0.39	0.49	ALNY
EXEL	0.0	-0.34		0.55	-0.6	-0.25	-0.18	-0.71	-0.8	0.24	EXEL
HALO	0.0	0.38	0.55		-0.63	-0.28	-0.65	-0.91	-0.57	0.79	HALO
ARWR	0.0	0.16	-0.6	-0.63		0.65	0.21	0.73	0.82	-0.18	ARWR
INCY	0.0	0.12	-0.25	-0.28	0.65		-0.17	0.32	0.45	0.01	INCY
IONS	0.0	-0.32	-0.18	-0.65	0.21	-0.17		0.6	0.21	-0.76	IONS
APLS	0.0	-0.15	-0.71	-0.91	0.73	0.32	0.6		0.76	-0.67	APLS
PCVX	0.0	0.39	-0.8	-0.57	0.82	0.45	0.21	0.76		-0.26	PCVX
LQDA	0.0	0.49	0.24	0.79	-0.18	0.01	-0.76	-0.67	-0.26		LQDA
	SGEN	ALNY	EXEL	HALO	ARWR	INCY	IONS	APLS	PCVX	LQDA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PCVX	+ 0.82	ARWR
LQDA	+ 0.79	HALO
PCVX	+ 0.76	APLS
APLS	+ 0.73	ARWR
INCY	+ 0.65	ARWR
APLS	+ 0.6	IONS

High negative correlations

APLS	- 0.91	HALO
PCVX	- 0.8	EXEL
LQDA	- 0.76	IONS
APLS	- 0.71	EXEL
LQDA	- 0.67	APLS
IONS	- 0.65	HALO

Risk-Adjusted Indicators

There is a big difference between Biomarin Stock performing well and Biomarin Pharmaceutical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biomarin Pharmaceutical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SGEN	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ALNY	1.97	0.34	0.16	0.26	1.86	(2.45)	4.69	(3.48)	15.40
EXEL	1.62	0.10	0.04	0.18	2.55	(1.54)	4.41	(3.83)	14.29
HALO	1.05	0.45	0.39	1.04	0.70	(1.24)	2.54	(1.75)	7.81
ARWR	2.74	(0.43)	0.00	(0.26)	0.00	0.00	4.73	(6.35)	19.61
INCY	1.43	(0.13)	0.00	(0.43)	0.00	0.00	2.63	(4.30)	12.72
IONS	2.00	(0.14)	0.00	(0.17)	0.00	0.00	4.42	(3.94)	10.86
APLS	2.13	(0.42)	0.00	(0.44)	0.00	0.00	4.11	(4.33)	20.77
PCVX	2.21	(0.21)	0.00	(0.22)	0.00	0.00	3.86	(4.85)	19.90
LQDA	2.12	0.61	0.21	0.42	2.24	(2.33)	4.82	(4.00)	13.55

Biomarin Pharmaceutical Corporate Management

Laura Woodhead	VP Counsel	Profile
George Davis	Chief VP	Profile
Traci McCarty	Group Relations	Profile
Jonathan Day	Executive Science	Profile
Cristin Hubbard	Executive Officer	Profile
Marni Kottle	Executive Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC